These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 11366889)

  • 1. Extended warning on Didanosine-related pancreatitis.
    Res Initiat Treat Action; 1999 Dec; 5(5):22-3. PubMed ID: 11366889
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ddI, d4T, Hydroxyurea: new pancreatitis warning.
    AIDS Treat News; 1999 Nov; (No 331):1-3. PubMed ID: 11367125
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hydroxyurea in combination with didanosine and stavudine in antiretroviral-experienced HIV-infected subjects with a review of the literature.
    Rossero R; Asmuth DM; Grady JJ; McKinsey DS; Green S; Andron L; Pollard RB
    Int J STD AIDS; 2003 May; 14(5):350-5. PubMed ID: 12803944
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drug Points: pancreatitis associated with hydroxyurea in combination with didanosine.
    Longhurst HJ; Pinching AJ
    BMJ; 2001 Jan; 322(7278):81. PubMed ID: 11154621
    [No Abstract]   [Full Text] [Related]  

  • 5. Incidence of pancreatitis in HIV-infected patients receiving nucleoside reverse transcriptase inhibitor drugs.
    Moore RD; Keruly JC; Chaisson RE
    AIDS; 2001 Mar; 15(5):617-20. PubMed ID: 11316999
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interrupting HAART; Hydroxyurea; five+ drug therapy - report from the RIGHT Conference.
    Levin J
    AIDS Treat News; 1999 May; (No 318):3-4. PubMed ID: 11366456
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New dosing of ddI (Videx) and Nelfinavir (Viracept) approved.
    Highleyman L
    BETA; 1999; 12(4):3. PubMed ID: 11367246
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of antiretroviral therapy in the incidence of pancreatitis in HIV-positive individuals in the EuroSIDA study.
    Smith CJ; Olsen CH; Mocroft A; Viard JP; Staszewski S; Panos G; Staub T; Blaxhult A; Vetter N; Lundgren JD
    AIDS; 2008 Jan; 22(1):47-56. PubMed ID: 18090391
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A randomized trial to investigate the recycling of stavudine and didanosine with and without hydroxyurea in salvage therapy (RESTART).
    Stebbing J; Nelson M; Orkin C; Mandalia S; Bower M; Pozniak A; Gazzard B
    J Antimicrob Chemother; 2004 Mar; 53(3):501-5. PubMed ID: 14762056
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incidence of pancreatitis in HIV-infected patients: comment on findings in EuroSIDA cohort.
    Fessel J; Hurley LB
    AIDS; 2008 Jan; 22(1):145-7. PubMed ID: 18090403
    [No Abstract]   [Full Text] [Related]  

  • 11. Warning for pregnant women on HIV therapy.
    FDA Consum; 2001; 35(3):5. PubMed ID: 11458554
    [No Abstract]   [Full Text] [Related]  

  • 12. Is Hydroxyurea for real?
    Mascolini M
    J Int Assoc Physicians AIDS Care; 1998 Aug; 4(8):6-16, 18. PubMed ID: 11365731
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acute pancreatitis associated with different combination therapies in patients infected with human immunodeficiency virus.
    Guo JJ; Jang R; Louder A; Cluxton RJ
    Pharmacotherapy; 2005 Aug; 25(8):1044-54. PubMed ID: 16207094
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acute onset of pancreatitis with concomitant use of tenofovir and didanosine.
    Kirian MA; Higginson RT; Fulco PP
    Ann Pharmacother; 2004 Oct; 38(10):1660-3. PubMed ID: 15340130
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Excess peripheral neuropathy in patients treated with hydroxyurea plus didanosine and stavudine for HIV infection.
    Cepeda JA; Wilks D
    AIDS; 2000 Feb; 14(3):332-3. PubMed ID: 10716516
    [No Abstract]   [Full Text] [Related]  

  • 16. Indinavir-induced renal failure.
    Chen SC; Nankivell BJ; Dwyer DE
    AIDS; 1998 Mar; 12(4):440-1. PubMed ID: 9520176
    [No Abstract]   [Full Text] [Related]  

  • 17. Nucleoside analogues and mitochondrial toxicity.
    Fleischer R; Boxwell D; Sherman KE
    Clin Infect Dis; 2004 Apr; 38(8):e79-80. PubMed ID: 15095236
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New questions about an old combination--ddI + d4T.
    Proj Inf Perspect; 2003 Jan; (35):13-4. PubMed ID: 12647675
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term hydroxyurea in combination with didanosine and stavudine for the treatment of HIV-1 infection. Swiss HIV Cohort Study.
    Rutschmann OT; Vernazza PL; Bucher HC; Opravil M; Ledergerber B; Telenti A; Malinverni R; Bernasconi E; Fagard C; Leduc D; Perrin L; Hirschel B
    AIDS; 2000 Sep; 14(14):2145-51. PubMed ID: 11061656
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics, safety and anti-human immunodeficiency virus (HIV) activity of hydroxyurea in combination with didanosine.
    Luzzati R; Di Perri G; Fendt D; Ramarli D; Broccali G; Concia E
    J Antimicrob Chemother; 1998 Oct; 42(4):565-6. PubMed ID: 9818769
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.